Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease

American Journal of Human Genetics

Volumn 77, Issue 2, 2005, Pages 252-264

  Oliveira, Sofia A ^a   Li, Yi Ju ^a   Noureddine, Maher A ^a   Züchner, Stephan ^a   Qin, Xuejun ^a   Pericak Vance, Margaret A ^a   Vance, Jeffery M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ENHANCER BINDING PROTEIN 3; INITIATION FACTOR 2 B3; PROTEIN PARK10; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 1P; EIF2B GENE; EIF2B3 GENE; ENHANCER REGION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; HIVEP3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; ONSET AGE; PARK10 GENE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLATION INITIATION; USP24 GENE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 22544472702     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/432588     Document Type: Article

References (37)

1. Abecasis GR, Cardon LR, Cookson WO (2000) A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279-292
2. Abecasis GR, Cookson WO (2000) GOLD - graphical overview of linkage disequilibrium. Bioinformatics 16:182-183
3. Allen CE, Mak CH, Wu LC (2002) The κB transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study. BMC Immunol 3:10
4. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
5. Antic D, Keene JD (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61:273-278
6. Blomqvist ME, Silburn PA, Buchanan DD, Andreasen N, Blennow K, Pedersen NL, Brookes AJ, Mellick GD, Prince JA (2004) Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 5:115-119
7. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120
8. Destefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Gunman M, Montgomery E, et al (2002) PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet 70:1089-1095
9. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Fahn S, Lang AE, Martinez-Martin P, Tilley B, Van Hilten B, Cleczka C, Seidl L (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738-750
10. Hauser MA, Li YJ, Takeuchi S, Walters R, Noureddine M, Maready M, Darden T, Hulette C, Martin E, Hauser E, Xu H, Schmechel D, Stenger JE, Dietrich F, Vance J (2003) Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet 12:671-677
11. Hauser MA, Li YJ, Xu H, Stenger J, Noureddine M, Shao Y, Gullans S, Scherzer CR, Jensen R, McLaurin A, Scott B, Jewett RM, Hulette C, Schmechel DE, Vance JM (2005) Expression profiling of substantia nigra in Parkinson, PSP, and FTDP-17. Arch Neurol 62:917-921
12. Haynes C, Speer MC, Peedin M, Roses AD, Haines JL, Vance JM, Pericak-Vance MA (1995) PEDIGENE: a comprehensive data management system to facilitate efficient and rapid disease gene mapping. Am J Hum Genet Suppl 57:A193
13. Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S (2002) A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 52:549-555
14. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM (2004) Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 26:61-69
15. Hubble JP, Weeks CC, Nance M, Watts RL, Koller WC, Stern MB, Colcher A, Ondo W, Jankovic J, Goetz C, Pappart E, Deane-Glaxo WPGC, Stajich JM, Scott BL, Vance JM, Pericak-Vance MA (1999) Parkinson's disease: clinical features in sibships. Neurology Suppl 52:A13
16. Inamura N, Nawa H, Takei N (2003) Developmental changes of eukaryotic initiation factor 2B subunits in rat hippocampus. Neurosci Lett 346:117-119
17. Karamohamed S, Destefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, et al (2003) A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology 61:1557-1561
18. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
19. Kolsch H, Linnebank M, Lutjohann D, Jessen F, Wullner U, Harbrecht U, Thelen KM, Kreis M, Hentschel F, Schulz A, von Bergmann K, Maier W, Heun R (2004) Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63:2255-2260
20. Laird NM, Horvath S, Xu X (2000) Implementing a unified approach to family-based tests of association. Genet Epidemiol Suppl 1 19:S36-S42
21. Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA (2003) Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J Biol Chem 278:16567-16578
22. Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH (1998) Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. Hum Genet 103:424-427
23. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner CB, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JA (2004) Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62:2005-2009
24. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, et al (2003) Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12:3259-3267
25. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, et al (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70:985-993
26. Lopez OL, Smith G, Meltzer CC, Becker JT (1999) Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry Neuropsychol Behav Neurol 12: 184-192
27. Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER (2003) Genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol 25:203-213
28. Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67:146-154
29. Monks SA, Kaplan NL (2000) Removing the sampling restrictions from family-based tests of association for a quantitative-trait locus. Am J Hum Genet 66:576-592
30. Noureddine MA, Li YJ, van der Walt JM, Walters R, Jewett RM, Xu H, Wang T, Walter JW, Scott BL, Hulette C, Schmechel DE, Stenger J, Dietrich F, Vance JM, Hauser MA (2005) Genornic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra. Mov Disord (electronically published June 17; available at: http://www3.interscience.wiley. com/cgi-bin/abstract/110541328) (accessed 22 June 2005)
31. Oukka M, Kim ST, Lugo G, Sun J, Wu LC, Glimcher LH (2002) A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2. Mol Cell 9:121-131
32. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der BM, de Munain AL, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600
33. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
34. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, et al (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286: 2239-2244
35. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160
36. van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51:264-270
37. Zaykin D, Zhivotovsky L, Weir BS (1995) Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96:169-178